Association of bone mineral density with polymorphism of the estrogen receptor gene

PvuII and XbaI restriction fragment length polymorphisms (RFLPs) of the estrogen receptor (ER) gene and its relation to bone mineral density (BMD) were examined in 238 postmenopausal healthy women aged 45–91 years (66.3 ± 0.6 years, mean ± standard error of the mean [SEM]) in Japan. The RFLPs were represented as Pp (PvuII) and Xx (XbaI), with capital letters signifying the absence of and small letters the presence of restriction sites. In the PPxx genotype (n = 18), Z score values of BMD were significantly lower than those for other genotypes (n = 220) (lumbar spine, −0.746 vs. −0.065 [p = 0.022]; total body, −0.482 vs. 0.308 [p = 0.002]). We classified the subjects into three genotypes with allelic haplotype: homozygote of the Px haplotype was expressed as the 11 genotype, heterozygote of the Px haplotype as the 10 genotype, and the one lacking the Px haplotype as the 00 genotype. The PpXx genotype was not included in this analysis because the allelic haplotypes are uncertain. The Px haplotype was associated with a low BMD in postmenopausal women (Z score for the lumbar spine, −0.746 vs. −0.279 vs. 0.083, for the 11, 10, 00 genotypes, respectively [p = 0.029]; Z score for the total body, −0.482 vs. 0.164 vs. 0.427, respectively [p = 0.003]). We suggest that some variation of the ER gene linked to these RFLPs is associated with low BMD and that this at least partly explains the cause of postmenopausal osteoporosis in Japanese women.

[1]  B. Dawson-Hughes,et al.  The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  D. Uebelhart,et al.  Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. , 1990, Bone and mineral.

[3]  S. Lehrer,et al.  Identification of a variant form of the human estrogen receptor with an amino acid replacement. , 1989, Nucleic acids research.

[4]  B. Dawson-Hughes,et al.  Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Y. Ouchi,et al.  Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells. , 1994, Endocrinology.

[6]  H. Melhus,et al.  Vitamin D receptor genotypes in osteoporosis , 1994, The Lancet.

[7]  A. Wilcox,et al.  Risk of miscarriage and a common variant of the estrogen receptor gene. , 1993, American journal of epidemiology.

[8]  J. Shine,et al.  Human estrogen receptor (ESR) gene locus: PssI dimorphism. , 1988, Nucleic acids research.

[9]  R. Lindsay,et al.  LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.

[10]  T. Spector,et al.  Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain , 1995, BMJ.

[11]  C. Langman,et al.  Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  J. Hopper,et al.  Genetic determinants of bone mass in adults. A twin study. , 1987, The Journal of clinical investigation.

[13]  S. Thung,et al.  Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer , 1990, The Lancet.

[14]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[15]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[16]  W. McGuire,et al.  Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. , 1989, Cancer research.

[17]  L. del Senno,et al.  PvuII RFLP inside the human estrogen receptor gene. , 1987, Nucleic acids research.

[18]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[19]  J. Christian,et al.  Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. , 1994, The Journal of clinical investigation.

[20]  C. Slemenda,et al.  Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[22]  S. Lehrer,et al.  Estrogen receptor variant and hypertension in women. , 1993, Hypertension.

[23]  W D Dupont,et al.  Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. , 1992, Cancer research.

[24]  A. Asaka,et al.  Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women , 1994, The Lancet.

[25]  K. Korach,et al.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Shiraki,et al.  Sandwich immunoassay for intact human osteocalcin. , 1992, Clinical chemistry.

[27]  K. Korach.  Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[28]  P. Carpenter,et al.  Estrogen replacement therapy: current recommendations. , 1988, Mayo Clinic proceedings.